Ravi Anchoori

1.0k citations
26 papers · 788 indexed · h-index 16
Topics
Ubiquitin and proteasome pathways (13 papers)Peptidase Inhibition and Analysis (7 papers)Endoplasmic Reticulum Stress and Disease (4 papers)
Partner nations
United StatesItalyIndia

In The Last Decade

Ravi Anchoori

26 papers receiving 776 citations

Peers

Ravi Anchoori
Comparison fields: 5 of 79
  • Molecular Biology 541
  • Oncology 209
  • Organic Chemistry 107
  • Epidemiology 93
  • Cell Biology 78
Replace Eva‐Laure Matera with:
Eva‐Laure Matera France
Yunxue Zhao China
Diane K. Luci United States
Tohru Obata Japan
Suhasini Joshi United States
Nicole Caspers United States
Wen‐Hsing Lin Taiwan
Anton Cheltsov United States
Chunwei Cheng China
Kenichiro Doi Japan
Ravi Anchoori relative to Eva‐Laure Matera France Eva‐Laure Matera's profile →
Citations per field
00.5×1.5×2.3×
Eva‐Laure Matera · 1×
Citations per year

Countries citing papers authored by Ravi Anchoori

Since Specialization
Citations

This map shows the geographic impact of Ravi Anchoori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Anchoori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Anchoori more than expected).

Fields of papers citing papers by Ravi Anchoori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Anchoori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Anchoori. The network helps show where Ravi Anchoori may publish in the future.

Co-authorship network of co-authors of Ravi Anchoori

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Anchoori. A scholar is included among the top collaborators of Ravi Anchoori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Anchoori. Ravi Anchoori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 6
4 10
5 14
6 31
7 23
8 13
9 45
10 57
11 125
12 48
13 33
14 31
15 81
16 17
17 44
18 6
19 3
20 29

About Ravi Anchoori

Ravi Anchoori is a scholar working on Cell Biology, Molecular Biology and Oncology, having authored 26 papers that have together received 788 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (13 papers), Peptidase Inhibition and Analysis (7 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). The work is most often cited by research in Molecular Biology (541 citations), Oncology (209 citations) and Cell Biology (78 citations). Ravi Anchoori has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Richard B.S. Roden, Saeed R. Khan, Kylie J. Walters, Rachel I. Vogel, Martina Bazzaro, Yoshie Iizuka, Robert Z. Orlowski, Balasubramanyam Karanam, Shiwen Peng and Chien‐Fu Hung. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026